Position history for Orbis Allan Gray Ltd's holdings in CRISPR THERAPEUTICS AG
Orbis Allan Gray Ltd holds 6.1M shares of CRSP (CRISPR THERAPEUTICS AG), worth $290.5M as of 2026-Q1. The position was increased (+2.6% shares). CRSP represents 1.2% of Orbis Allan Gray Ltd's portfolio.
Current Value
$290.5M
Current Shares
6.1M
Total Value Change
+$232.4M
Total Shares Change
+4.6M
Other major holders of CRSP: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Increased |
| 6.1M |
+2.6% |
| $290.5M |
| 1.2% |
| $58.06 |
50 |
| 2025-Q4 | Increased | 6M | +19.4% | $312M | 1.3% | $53.19 | 58 |
| 2025-Q3 | Increased | 5M | +80.2% | $322.9M | 1.4% | $63.77 | 75 |
| 2025-Q2 | Increased | 2.8M | +76.9% | $134.5M | 0.7% | $47.49 | 65 |
| 2025-Q1 | Increased | 1.6M | +5.9% | $53.2M | 0.3% | $36.99 | 37 |
| 2024-Q4 | New | 1.5M | - | $58.1M | 0.3% | $38.65 | 49 |